Aims. We compared the outcome of total hip arthroplasty (THA) in obese
patients who previously underwent
Aims. Our aim was to determine whether, based on the current literature,
bariatric surgery prior to total hip (THA) or total knee arthroplasty
(TKA) reduces the complication rates and improves the outcome following
arthroplasty in obese patients. Methods. A systematic literature search was undertaken of published and
unpublished databases on the 5 November 2015. All papers reporting
studies comparing obese patients who had undergone bariatric surgery
prior to arthroplasty, or not, were included. Each study was assessed
using the Downs and Black appraisal tool. A meta-analysis of risk ratios
(RR) and 95% confidence intervals (CI) was performed to determine
the incidence of complications including wound infection, deep vein
thrombosis (DVT), pulmonary embolism (PE), revision surgery and
mortality. Results. From 156 potential studies, five were considered to be eligible
for inclusion in the study. A total of 23 348 patients (657 who
had undergone
Background. Total Knee Replacement (TKR) is technically demanding, time consuming and has higher complication rates in super obese (BMI>45) patients.
Introduction. Weight is a modifiable risk factor for osteoarthritis (OA) progression. Despite the emphasis on weight loss, data quantifying the changes seen in joint biomechanics are limited.
The purpose of this study was to determine the association between prior sleeve gastrectomy in patients undergoing primary total hip and knee arthroplasty, and 90-day complications, incidence of revision arthroplasty, and patient-reported outcome scores at final follow-up. This is a retrospective, single-centre analysis. Patients undergoing primary hip or knee arthroplasty with a prior sleeve gastrectomy were eligible for inclusion (n = 80 patients). A morbidly obese control group was established from the same institutional registry using a 1:2 match, for cases:controls with arthroplasty based on propensity score using age, sex, pre-sleeve gastrectomy BMI, Current Procedural Terminology code to identify anatomical location, and presurgical haemoglobin A1C. Outcomes included 90-day complications, incidence of revision arthroplasty, and patient-reported outcome scores at final follow-up. Multivariable logistic regressions evaluated associations of underlying preoperative demographic and treatment characteristics with outcomes.Aims
Methods
The August 2024 Knee Roundup. 360. looks at: Calcification’s role in knee osteoarthritis: implications for surgical decision-making; Lower complication rates and shorter lengths of hospital stay with technology-assisted total knee arthroplasty; Revision surgery: the hidden burden on surgeons; Are preoperative weight loss interventions worthwhile?; Total knee arthroplasty with or without prior
The April 2023 Knee Roundup. 360. looks at: Does
Introduction. Many patients with obesity experience knee pain. Excess body weight is a modifiable risk factor for osteoarthritis (OA) and weight loss is encouraged in patients with OA.
Aims. The aim of this study was to observe the implications of withholding total joint arthroplasty (TJA) in morbidly obese patients. Patients and Methods. A total of 289 morbidly obese patients with end-stage osteoarthritis were prospectively followed. There were 218 women and 71 men, with a mean age of 56.3 years (26.7 to 79.1). At initial visit, patients were given information about the risks of TJA in the morbidly obese and were given referral information to a bariatric clinic. Patients were contacted at six, 12, 18, and 24 months from initial visit. Results. The median body mass index (BMI) at initial visit was 46.9 kg/m. 2. (interquartile range (IQR) 44.6 to 51.3). A total of 82 patients (28.4%) refused to follow-up or answer phone surveys, and 149 of the remaining 207 (72.0%) did not have surgery. Initial median BMI of those 149 was 47.5 kg/m. 2. (IQR 44.6 to 52.5) and at last follow-up was 46.7 kg/m. 2. (IQR 43.4 to 51.2). Only 67 patients (23.2%) went to the bariatric clinic, of whom 14 (20.9%) had
Given the growing prevalence of obesity around
the world and its association with osteoarthritis of the knee, orthopaedic
surgeons need to be familiar with the management of the obese patient
with degenerative knee pain. The precise mechanism by which obesity
leads to osteoarthritis remains unknown, but is likely to be due
to a combination of mechanical, humoral and genetic factors. . Weight loss has clear medical benefits for the obese patient
and seems to be a logical way of relieving joint pain associated
with degenerative arthritis. There are a variety of ways in which
this may be done including diet and exercise, and treatment with
drugs and
The prevalence of Class III Obesity (BMI ≥ 40 kg/m25) in black women is 18%, three times the 6 national average. Class III obesity is associated with mobility limitations, particularly hip joint 7 deterioration. Therefore black women are highly likely to come to the attention of orthopedic 8 surgeons. Weight loss associated with
C.D. Watts, J.R. Martin, M. T. Houdek, M. P. Abdel, D. G.Lewallen, M. J. Taunton Prior
Introduction. Morbid obesity (BMI>40) is a significant risk factor for complications following total joint arthroplasty (TJA). As such many have a restrictive practice of withholding elective primary TJA in the morbidly obese. The purpose of this study was to observe the implications of this practice. Methods. From 2012 to 2014, 289 patients with morbid obesity and end-stage OA of the hip or knee were prospectively followed. At initial visit, patients were given a packet on risks of TJA in the morbidly obese and referral information to a weight loss clinic. Patients were contacted at 6, 12, 18 and 24 months from initial visit for PROs, and BMI changes. The average age of patients was 56 (26.7–79.1) there were 218 females and 71 males. Results. The average BMI at initial visit was 46.9 (39.9–68.2). 85 patients (29%) refused additional follow up or to answer phone surveys regarding their status. 146 patients (50.5%) have not had surgery. Initial BMI in this cohort was 47.4 (39.9–68.6) and at last follow up was 46.8 (28.9–70.8). Of those, 11 (7.5%) had a last follow up BMI≤40. Only 23% of patients went to the bariatric clinic and 13% had
The following papers will be discussed during this session: 1) Staph Screening and Treatment Prior to Elective TJA; 2) Unfulfilled Expectations Following TJA Procedures; 3) Thigh Pain in Short Stem Cementless Components in THR; 4) Is the Direct Anterior Approach a Risk Factor for Early Failure?; 5) THA Infection - Results of a 2nd 2-Stage Re-implantation - Clinical Trial of Articulating and Static Spacers; 6) THA Revision - Modular vs. Non Modular Fluted Tapered Stems-Total Femoral Replacement for Femoral Bone Loss - Cage + TM Augment vs. Cup Cage for Acetabular Bone Loss; 7) Do Injections Increase the Risk of Infection Prior to TKA?; 8) Long-Acting Opioid Use Predicts Perioperative Complication in TJA; 9) UKA vs. HTO in Patients Under 55 at 5–7 years; 10) Stemming Tibial Component in TKA Patients with a BMI > 30; 11) The Effect of
Obesity is a leading public health concern and it is increasing in prevalence over the last 20 years. Obesity prevalence has doubled in adults and tripled in adolescents. The United States is the leading country in terms of percent obesity. Most alarming is the fact that the fastest growing rates of obesity are in the highest BMI groups. The issue of obesity is a particular concern to arthroplasty surgeons since there is an association between the increasing incidence of obesity and the increasing rate of joint replacement. Also of concern is that obese patients tend to be younger and complication rates and revision rates are higher in young patients which is only compounded by the presence of obesity. The risk of virtually every major complication is substantially higher in obese patients. Of concern, however, is a recent study indicating that
Outcomes of THA after Hip Arthroscopy. Hip Injections and Rapidly Progressing Joint Degeneration. Procedure Duration Wound Complications & LOS. Losing Weight Following TKA and its Influence on Outcome. Radiographic Severity of Arthritis & Patient Satisfaction in TKA. Intra-wound Vancomycin Powder Reduces Infections in TJA. Increased Non-stemmed Tibial Failures with BMI ≥ 35. Influence of Component Alignment on Outcome in Varus TKA. New TKA Designs - Do Patients Notice?.
In the USA, 34.9% of adults are currently obese (BMI > 30). Growth in total knee arthroplasty (TKA) is outpacing growth in total hip arthroplasty (THA) largely due to a differential utilization of TKA in overweight patients in the USA. In a recent study, 54.5% of patients reporting to arthroplasty clinics in the USA were obese. From 2006–2010, 61.2% of primary unilateral TKA patients in the USA ACS-NSQIP database were obese. Arthroplasty surgeons are directly affected by the obesity epidemic and need to understand how to safely offer a range of peri-operative care for these patients in order to insure good clinical outcomes. Pre-operative care for the obese patient involves nutritional counseling, weight loss methods, consideration for
What are the data on obesity and THA risk? Which complications are elevated? If you decide on surgery, how can you minimise complications? These are timely questions because the rates of obesity are rising in the US and in many other parts of the world. Does obesity increase risk of THA complications? Answer: yes: at least for some complications. Complications which are increased: infection, wound healing, nerve injury; possibly: dislocation, periprosthetic fractures. The data are mixed on whether aseptic loosening and/or bearing surface wear problems are increased in the obese. Higher BMI may be offset by lower activity levels, particularly in a congruent joint such as the hip. Outcomes of THA in obese: Lower function scores and activity scores compared to nonobese. But good pain relief and the preoperative to postoperative change in functional scores is similar to non-obese. Is there a critical BMI threshold above which complications become unacceptable? Several studies show BMI ≥40 associated with strong risk of complications. One study from Mayo Clinic on patients with BMI ≥50 showed a 39% surgical complication rate, a 12% medical complication rate, and a high mortality rate in the several years after THA. Individualise operative decisions based on risk/benefit analysis for each patient. If you decide to operate, how can you minimise risk? Lose weight before surgery by diet: often ineffective, but worth trying. Lose weight before THA with